Shattuck Labs, Inc.
NASDAQ:STTKBiotechnology
+$0.11 today
- Market cap
- $455.24M
- Beta
- 1.09
- P/E (TTM)
- -10.9
- EPS (TTM)
- -$0.44
Volume 2.08M
Average 0.69M
STTK Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Shattuck Labs, Inc.NASDAQ: STTK
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses growth accelerates
Q1 FY2026 other income / expenses of $778K rose 13.2% year over year, ahead of the -35.2% change in trailing-twelve-month other income / expenses. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +24.9% a year.
Context
- Other income / expenses amounted to 269.9% of revenue in FY2025, up 179.8 pp from a year earlier.
- Other income / expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +13.2% holds above the trailing-twelve-month pace of -35.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 2.7M USD
- Year-over-year change
- -47.7%
- 4-year CAGR
- +73.9%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.7M | -47.7% |
| FY2024 | 2024-12-31 | 5.16M | +10.7% |
| FY2023 | 2023-12-31 | 4.66M | +236.6% |
| FY2022 | 2022-12-31 | 1.38M | +369.2% |
| FY2021 | 2021-12-31 | 295K | — |
Other Income / Expenses vs competitors
How STTK compares with its peers on the latest reported figures
- Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -35.2% is the 8th highest of 10, against a peer median of +92.5%.
- Other income / expenses amounts to 279.0% of revenue for STTK, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥21.66M CNY | +125.8% | — | — |
| LTM Mar 2026 | $10.06M USD | +10.6% | +14.6% | — | |
| LTM Sep 2026 | $8.6M USD | -33.8% | +20.0% | 2.3% | |
| LTM Sep 2026 | $3.68M USD | +270.3% | +29.5% | — | |
| LTM Jun 2026 | $3.29M USD | +309.8% | +31.3% | — | |
| LTM Mar 2026 | $3.06M USD | +4174.1% | -1.2% | 25.7% | |
| LTM Mar 2026 | $2.79M USD | -35.2% | +24.9% | 279.0% | |
| LTM Mar 2026 | -$399K USD | +92.5% | — | 0.2% | |
| LTM Mar 2026 | -$1.44M USD | -681.1% | — | — | |
| LTM Mar 2026 | -$4.4M USD | -99.3% | — | — | |
| Peer median (excluding STTK) | — | +92.5% | +20.0% | 2.3% | |
Competitors are the stored peer set for STTK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 30.02M | 652K | 1.66M | 5.72M | 1M |
| Cost of Revenue | 1.38M | 82.2M | 4.04M | 4.89M | 0 |
| Gross Profit | 28.64M | (81.55M) | (2.39M) | 827K | 1M |
| Gross Margin | 95.4% | -12507.2% | -143.9% | 14.5% | 100.0% |
| Research & Development | 56.56M | 82.9M | 74.31M | 67.21M | 35.27M |
| Selling, General & Admin | 18.72M | 19.68M | 19.3M | 19.08M | 17.24M |
| Operating Expenses | 73.91M | 21.78M | 89.57M | 81.39M | 52.51M |
| Depreciation & Amortization | 1.38M | 3.07M | 4.04M | 3.83M | 3.69M |
| EBITDA | (43.59M) | (98.87M) | (83.26M) | (71.58M) | (45.12M) |
| EBITDA Margin | -145.2% | -15164.4% | -5024.5% | -1251.2% | -4512.1% |
| Operating Income | (45.27M) | (103.33M) | (91.96M) | (80.57M) | (51.51M) |
| Operating Margin | -150.8% | -15848.0% | -5549.6% | -1408.3% | -5150.8% |
| Interest Income | 625K | 1.59M | 4.67M | 5.17M | 2.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 295K | 1.38M | 4.66M | 5.16M | 2.7M |
| Income Before Tax | (44.97M) | (101.95M) | (87.3M) | (75.41M) | (48.81M) |
| Pre-Tax Margin | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (44.97M) | (101.95M) | (87.3M) | (75.41M) | (48.81M) |
| Net Margin | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |
| EPS (Basic) | (1.07) | (2.41) | (2.05) | (1.49) | (0.70) |
| EPS (Diluted) | (1.07) | (2.41) | (2.05) | (1.49) | (0.70) |
| Weighted Avg Shares | 42.03M | 42.38M | 42.6M | 50.76M | 69.58M |
| Weighted Avg Shares (Diluted) | 42.03M | 42.38M | 42.6M | 50.76M | 69.58M |
Shattuck Labs, Inc.
NASDAQ:STTK
Intrinsic Alpha fair value
Locked
Current Price
$4.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.